Comment on

• Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot study.

  Franchi F, Seminara P, Codacci Pisanelli G, Guazzugli Bonaiuti VP, Giovagnorio F, Gualdi G. Franchi F, et al. Eur J Cancer. 1994;30A(10):1420-3. doi: 10.1016/0959-8049(93)e0161-i. Eur J Cancer. 1994. PMID: 7833095
• A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer. Cuneo Lung Cancer Study Group (CuLCaSG).

  Buccheri G, Ferrigno D. Buccheri G, et al. Eur J Cancer. 1994;30A(10):1424-31. doi: 10.1016/0959-8049(94)00286-e. Eur J Cancer. 1994. PMID: 7833096 Clinical Trial.
• Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer.

  Gadducci A, Brunetti I, Muttini MP, Fanucchi A, Dargenio F, Giannessi PG, Conte PF. Gadducci A, et al. Eur J Cancer. 1994;30A(10):1432-5. doi: 10.1016/0959-8049(94)00231-s. Eur J Cancer. 1994. PMID: 7833097 Clinical Trial.
• In vitro effect of lonidamine on the cytotoxicity of mitomycin C and BCNU in human colon adenocarcinoma cells.

  Villa R, Zaffaroni N, Orlandi L, Bearzatto A, Costa A, Silvestrini R. Villa R, et al. Eur J Cancer. 1994;30A(10):1534-40. doi: 10.1016/0959-8049(94)e0162-w. Eur J Cancer. 1994. PMID: 7833114